Cargando…

Immunodeficiency and CARD-BCL10-MALT1

Detalles Bibliográficos
Autor principal:	Pérez de Diego, Rebeca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial: Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652963/ https://www.ncbi.nlm.nih.gov/pubmed/26287604

Ejemplares similares

Ancient Origin of the CARD–Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions
por: Staal, Jens, et al.
Publicado: (2018)

A CARD9 Founder Mutation Disrupts NF-κB Signaling by Inhibiting BCL10 and MALT1 Recruitment and Signalosome Formation
por: De Bruyne, Marieke, et al.
Publicado: (2018)

The CBM-opathies—A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex
por: Lu, Henry Y., et al.
Publicado: (2018)

Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling
por: Juilland, Mélanie, et al.
Publicado: (2018)

BCL10 – Bridging CARDs to Immune Activation
por: Gehring, Torben, et al.
Publicado: (2018)

BCL10-CARD11 Fusion Mimics an Active CARD11 Seed That Triggers Constitutive BCL10 Oligomerization and Lymphocyte Activation
por: Seeholzer, Thomas, et al.
Publicado: (2018)

Molecular architecture and regulation of BCL10-MALT1 filaments
por: Schlauderer, Florian, et al.
Publicado: (2018)

CARD10 cleavage by MALT1 restricts lung carcinoma growth in vivo
por: Israël, Laura, et al.
Publicado: (2021)

Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies
por: Juilland, Mélanie, et al.
Publicado: (2016)

Clinical and Immunological Features of Human BCL10 Deficiency
por: Garcia-Solis, Blanca, et al.
Publicado: (2021)

Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells
por: Rosenbaum, Marc, et al.
Publicado: (2019)

Auto-Ubiquitination-Induced Degradation of MALT1-API2 Prevents BCL10 Destabilization in t(11;18)(q21;q21)-Positive MALT Lymphoma
por: Noels, Heidi, et al.
Publicado: (2009)

Malt and Grain Whisky
Publicado: (1903)

Attacking MALT1 for ABC-DLBCL therapy
por: Krappmann, Daniel
Publicado: (2012)

Targeting Lymphomas Through MALT1 Inhibition
por: Fontan, Lorena, et al.
Publicado: (2012)

Bcl10 mutations in malignancy
por: Dyer, M J S
Publicado: (1999)

Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2020)

Extract Malt and Its Combinations
Publicado: (1879)

MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner
por: Demeyer, Annelies, et al.
Publicado: (2019)

MALT1-Deficient Mice Develop Atopic-Like Dermatitis Upon Aging
por: Demeyer, Annelies, et al.
Publicado: (2019)

Genomic crossroads between non-Hodgkin’s lymphoma and common variable immunodeficiency
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2022)

MALT1 protease activity in primary effusion lymphoma
por: Juilland, Mélanie, et al.
Publicado: (2017)

Trommer’s Extract of Malt
Publicado: (1880)

Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia
por: Ma, Yu, et al.
Publicado: (2014)

Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology
por: Martin, Kea, et al.
Publicado: (2020)

Combined Immunodeficiency Due to MALT1 Mutations, Treated by Hematopoietic Cell Transplantation
por: Punwani, Divya, et al.
Publicado: (2015)

Pharmacological Inhibition of MALT1 Ameliorates Autoimmune Pathogenesis and Can Be Uncoupled From Effects on Regulatory T-Cells
por: Biswas, Subhabrata, et al.
Publicado: (2022)

TRAF6 controls T cell homeostasis by maintaining the equilibrium of MALT1 scaffolding and protease functions
por: O’Neill, Thomas J., et al.
Publicado: (2023)

AIP augments CARMA1-BCL10-MALT1 complex formation to facilitate NF-κB signaling upon T cell activation
por: Schimmack, Gisela, et al.
Publicado: (2014)

MALT1-Dependent Cleavage of HOIL1 Modulates Canonical NF-κB Signaling and Inflammatory Responsiveness
por: Fung, Shan-Yu, et al.
Publicado: (2021)

Evaluation of the 10 Warning Signs in Primary and Secondary Immunodeficient Patients
por: Eldeniz, Fadime Ceyda, et al.
Publicado: (2022)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
por: Perez, Elena E., et al.
Publicado: (2021)

A Card
por: Jacobs, Jos.
Publicado: (1889)

A Card
por: Daniel, F. E.
Publicado: (1891)

Office Card
Publicado: (1879)

A Card
Publicado: (1868)

CARD9 Signaling, Inflammation, and Diseases
por: Liu, Xuanyou, et al.
Publicado: (2022)

The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival
por: Zhang, Shilei, et al.
Publicado: (2017)

BCL10GFP fusion protein as a substrate for analysis of determinants required for Mucosa-Associated Lymphoid Tissue 1 (MALT1)-mediated cleavage
por: Jou, Shin-Yi, et al.
Publicado: (2012)

Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts
por: Govender, Lerisa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jp8m1hk6laktagbol78ubau2il